Invention Grant
- Patent Title: Anti-EGFR antibodies and antibody drug conjugates
-
Application No.: US15808419Application Date: 2017-11-09
-
Publication No.: US10098968B2Publication Date: 2018-10-16
- Inventor: Edward B. Reilly , Andrew C. Phillips , Lorenzo Benatuil , Chung-Ming Hsieh , Jennifer Perez
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: Abbvie Inc.
- Current Assignee: Abbvie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Womble Bond Dickinson (US) LLP
- Agent Cristin H. Cowles; Kevin A. Fiala
- Main IPC: C07K16/28
- IPC: C07K16/28 ; C07K14/00 ; C07K16/30 ; A61K39/00 ; A61K47/68
Abstract:
The invention relates to anti-epidermal growth factor (EGFR) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
Public/Granted literature
- US20180125999A1 ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES Public/Granted day:2018-05-10
Information query
